SELLAS Life Sciences Group, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
SELLAS Life Sciences Group, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • SELLAS Life Sciences Group, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$7.11M, a 23.3% increase year-over-year.
  • SELLAS Life Sciences Group, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$32.3M, a 15.8% increase year-over-year.
  • SELLAS Life Sciences Group, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$37.3M, a 9.59% increase from 2022.
  • SELLAS Life Sciences Group, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$41.3M, a 99.5% decline from 2021.
  • SELLAS Life Sciences Group, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$20.7M, a 23.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$32.3M -$7.11M +$2.16M +23.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$34.4M -$7.47M +$1.37M +15.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$35.8M -$9.57M +$1.53M +13.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$37.3M -$8.14M +$985K +10.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$38.3M -$9.27M -$2.25M -32% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$36.1M -$8.84M -$426K -5.06% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$35.7M -$11.1M +$5.65M +33.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$41.3M -$9.12M -$2.52M -38.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$38.8M -$7.02M +$63K +0.89% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$38.8M -$8.41M -$3.8M -82.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$35M -$16.7M -$14.3M -597% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$20.7M -$6.6M -$2.88M -77.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$17.8M -$7.09M -$2.61M -58.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$15.2M -$4.61M -$188K -4.25% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$15M -$2.4M +$1.74M +42% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$16.8M -$3.72M +$3.7M +49.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$20.5M -$4.47M -$271K -6.45% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$20.2M -$4.43M -$1.29M -41.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$18.9M -$4.14M +$394K +8.68% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$19.3M -$7.42M +$5.9M +44.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-23
Q3 2019 -$25.2M -$4.2M -$3.91M -1349% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$21.3M -$3.13M +$2.93M +48.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$24.2M -$4.54M +$3.46M +43.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$27.7M -$13.3M -$4.54M -51.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-13
Q3 2018 -$23.1M -$290K +$4.17M +93.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$27.3M -$6.06M -$149K -2.52% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$27.1M -$8M -$3.39M -73.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$23.8M -$8.79M -$9.14M -2596% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-22
Q3 2017 -$14.6M -$4.46M +$2.47M +35.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$17.1M -$5.91M -$11.3M -210% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$5.79M -$4.6M +$11.9M +72.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$17.7M $352K +$20M Oct 1, 2016 Dec 31, 2016 10-K 2018-04-13
Q3 2016 -$37.7M -$6.93M +$11.1M +61.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$48.8M $5.39M +$21M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$69.9M -$16.5M -$5.96M -56.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$63.9M -$19.7M -$11.7M -147% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 -$52.2M -$18M -$11.9M -192% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$40.3M -$15.7M +$4.28M +21.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$44.6M -$10.5M -$8M -315% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$36.6M -$7.96M -$2.44M -44.2% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 -$34.2M -$6.17M +$756K +10.9% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$34.9M -$19.9M -$25.3M -470% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$9.59M -$2.54M +$14M +84.6% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$23.5M -$5.52M +$14.2M +72% Oct 1, 2013 Dec 31, 2013 10-K 2017-03-15
Q3 2013 -$37.7M -$6.93M +$11.1M +61.6% Jul 1, 2013 Sep 30, 2013 10-K 2017-03-15
Q2 2013 -$48.8M $5.39M +$21M Apr 1, 2013 Jun 30, 2013 10-K 2017-03-15
Q1 2013 -$69.9M -$16.5M -$5.96M -56.5% Jan 1, 2013 Mar 31, 2013 10-K 2017-03-15
Q4 2012 -$63.9M -$19.7M -$21.3M -1342% Oct 1, 2012 Dec 31, 2012 10-K 2017-03-15
Q3 2012 -$42.6M -$18M -$12.6M -229% Jul 1, 2012 Sep 30, 2012 10-K 2017-03-15
Q2 2012 -$30.1M -$15.7M -$11.9M -317% Apr 1, 2012 Jun 30, 2012 10-K 2017-03-15
Q1 2012 -$18.2M -$10.5M -$6.7M -174% Jan 1, 2012 Mar 31, 2012 10-K 2017-03-15
Q4 2011 -$11.5M $1.59M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-17
Q3 2011 -$5.48M -$1.34M -32.4% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$3.75M -$1.61M -75.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$3.84M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14
Q3 2010 -$4.14M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$2.14M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-10-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.